Study to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep Disorders

NCT03514732 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Disorder (Healthy Volunteers)

Interventions

DRUG: MELATONIN (MELATL07959)

Sponsor

Sanofi